Alexis N. Smith: How Apolipoproteins Influence Platelet Function
Alexis N. Smith, Postdoctoral Fellow at Versiti Inc., shared on LinkedIn about a recent article she and her colleagues co-authored, published in JTH, adding:
”Excited to share that my 1st first‑author publication from my postdoc has been published as a JTH Commentary in the Journal of Thrombosis and Haemostasis.
In this commentary, we discussed a recent paper by W. C. Schrottmaier et al., ‘Elevated levels of apolipoprotein C‑III impair platelet function and reduce thrombosis,’ which highlights an unexpected role for apoC‑III beyond its well‑known links to atherosclerosis.
Their work uncovered that apoC‑III can directly inhibit platelet activation and thrombus formation, providing an important foundation for ongoing research into how apolipoproteins influence platelet function.
Many thanks to my postdoctoral mentor, Ze Zheng, for the support and guidance.”
Title: Atherogenic apolipoprotein C-III may not be as bad as we thought
Authors: Alexis N. Smith, Ziyu Zhang, Ze Zheng
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering